Hip Replacements News
-
New real world study data on reduced risk of adverse kidney outcomes for Xarelto compared to VKA
In the prospective observational XARENO study, after a two year follow up period, Xarelto was associated with a reduced risk of adverse kidney outcomes and all-cause mortality in patients with non-valvular atrial fibrillation (NVAF) and advanced chronic kidney disease (CKD), compared to vitamin K antagonists (VKA) XARENO evaluated the impact of Xarelto in patients with NVAF and CKD, given that ...
By Bayer AG
-
Alfa Chemistry Enriches API Supply by Adding Lenalidomide, Parecoxib Sodium, and Rivaroxaban
As one of the leading chemical manufacturers and suppliers globally, Alfa Chemistry is well-prepared to provide a number of active pharmaceutical ingredients (APIs), such as donepezil and dexmedetomidine hydrochloride, for customers worldwide ranging from lab to commercial scale. Earlier this month, the company announced that three other APIs had been introduced for its global customers as well, ...
-
Grossmont Orthopaedic Medical Group Performs First Meniscus Replacement in San Diego with NUsurface Meniscus Implant
Dr. Scott A. Hacker, an expert in arthroscopic surgery, total joint replacements, sports medicine and fracture care, and Active Implants, a company that develops orthopedic implant solutions, today announced that the first meniscus replacement procedure in San Diego has been performed. Dr. Hacker is the only physician in San Diego County – and Grossmont Orthopedic Medical Group is one of ...
-
Active Implants SUN Clinical Trial for Persistent Knee Pain Now Underway in San Diego
Active Implants, a company that develops orthopedic implant solutions, today announced that the company’s SUN (Safety Using NUsurface) trial is now underway in San Diego. Dr. Scott A. Hacker at Grossmont Orthopaedic Medical Group is the only physician in San Diego County – and the center is one of just 10 sites nationwide – participating in the SUN clinical trial to evaluate the ...
-
CurvaFix Announces Participation in Orthopaedic Trauma Association Industry Sessions
BELLEVUE, Wash., Sept. 28, 2022 – CurvaFix, Inc., a developer of medical devices to repair fractures in curved bones, today announced the addition of three new members to its Surgeon Advisory Board. The new members bring together expertise in orthopedic traumatology, pelvis and acetabular trauma reconstruction, and Fragility Fractures of the Pelvis (FFP) to support CurvaFix’s focus on ...
-
Photodisinfection successfully eradicates pathogens associated with replacement joint infections
A research team in Zurich, Switzerland has presented results from an in vitro study showing that photodisinfection achieved >99.99% eradication (4-7 log10 kill) of the key pathogens in biofilms associated with implantable joint infections, with no reported regrowth. These results were presented at the recent Swiss Society for Microbiology (SSM) Annual Congress 2022 in Lausanne, Switzerland. ...
-
Doug Kohrs appointed to Sequana Medical Board of Directors
Sequana Medical NV (Euronext Brussels: SEQUA) (the “Company” or “Sequana Medical“), a pioneer in the treatment of drug-resistant fluid overload in liver disease and heart failure, today announces the appointment of Doug Kohrs as an independent Non-Executive Director of the Company. Mr. Kohrs is a highly experienced US executive with a track record of more than 40 years in ...
-
Coming Soon – The next addition to the EMPOWR Platform
EMPOWR Acetabular™ is DJO’s modern, premium, intelligently designed acetabular system featuring advanced fixation technologies, efficient instrumentation, and a feature enabling future dual mobility offering.1 This system – combined with our femoral stem options which all have 12/14 robust micro-threaded trunnions – provides surgeons a comprehensive THA solution for all ...
-
Rivaroxaban (Xarelto) approved in Japan for patients with peripheral artery disease (PAD) after revascularisation
The Ministry of Health, Labor and Welfare in Japan has approved the use of the oral Factor Xa inhibitor rivaroxaban (Xarelto™) (2.5 mg twice daily, used in combination with aspirin 81-100 mg once daily) to treat patients with peripheral artery disease (PAD) after revascularization. The approval is based on data from the Phase III VOYAGER PAD trial. This study demonstrated a positive ...
By Bayer AG
-
Former Professional Baseball Player Pain-Free after Knee Surgery with Active Robot Technology Available at INOV8 Surgical
THINK Surgical, Inc., an innovator in the field of orthopedic active robot surgery, is pleased to announce that Stefan Kreuzer, M.D.*, of INOV8 Surgical, a leading ambulatory surgical center (ASC) in Houston specializing in outpatient total joint procedures, is approaching a key milestone with THINK’s active robot technology. Dr. Kreuzer has performed nearly 90 procedures** with the ...
-
DePuy Synthes Acquires CUPTIMIZE™ Hip-Spine Analysis, Providing Technology to Help Surgeons Better Understand, Measure and Address Pelvic Tilt
On-site booth will host interactive experiences including product trials, hands-on demonstrations, and education Today, Johnson & Johnson MedTech* announced that DePuy Synthes,** The Orthopaedics Company of Johnson & Johnson, has acquired CUPTIMIZE™ Hip-Spine Analysis, giving surgeons an easy-to-use tool to better understand and address the impact of abnormal motion between the ...
-
HipXpert Now Supports DePuy Synthes’ PINNACLE
Surgical Planning Associates, Inc. announces a new HipXpert software release that now includes the addition of DePuy Synthes’ PINNACLE® Acetabular Cup System and the ACTIS®, CORAIL®, SUMMIT®, and TRI-LOCK® Hip Systems to our patient-specific surgery planning and navigation system. HipXpert’s open-platform, 3D surgery planning software now supports more than 20 ...
By HipXpert
-
OrthoGrid Brings the Power of Artificial Intelligence to Orthopedics!
OrthoGrid® Systems, Inc., is pleased to announce the OrthoGrid Hip AI application. Powered by artificial intelligence and machine learning, our Hip AI platform is the world's first-ever intraoperative hip replacement navigation system. OrthoGrid will showcase Hip AI at AAOS 2022, further defining OrthoGrid as a visionary leader in the next generation of orthopedic surgery enhanced by digital ...
-
Publication of Two-Year EVOKE Double-Blind Randomized Controlled Trial Results in JAMA Neurology Demonstrate Sustained Superiority of Evoke® Closed-Loop over Open-Loop Spinal Cord Stimulation
Saluda Medical Pty Limited (“Saluda Medical”), a global company on a mission to revolutionize the field of neuromodulation with an emerging portfolio of therapies driven by advanced closed-loop technologies designed to treat debilitating neurological disorders, today announced long-term results of its double-blind Level 1 EVOKE randomized controlled trial (RCT) published online in ...
-
Caira secures $5M financing to develop new standard of care in orthopedics
Caira Surgical announced its latest influx of $5M seed capital in an oversubscribed series seed financing that closed last month. Caira's investor syndicate includes smart-money venture and strategic MedTech investors. Caira's proprietary technology seeks to revolutionize the usability, safety, and accessibility of advanced surgical navigation and robotics for orthopedic surgery. The company's ...
-
U.S. FDA approves Xarelto to treat venous thromboembolism (VTE) and to prevent VTE in children
Xarelto is the only Factor Xa anticoagulant FDA approved for pediatric patients and offers a flexible weight-based dosing Xarelto is available in both oral tablet and liquid suspension formulations for use in appropriate children less than 18 years of age Convenient liquid formulation advances standard of care for children; alleviates administration challenges found with injectable ...
By Bayer AG
-
Microport Orthopedics announces first successful total knee replacement performed in the U.S. using Pixee Medical’s Knee+ Augmented-Reality Platform
MicroPort Orthopedics, a global leader in orthopedic devices and technologies, today announces the successful completion of the first surgery in the U.S. utilizing Pixee Medical, an FDA-cleared augmented reality surgical application for assistance in total knee arthroplasties. The surgery was performed by Dr. Antonia F. Chen, M.D., M.B.A., an orthopedic surgeon at Brigham and Women’s ...
-
Microport Orthopedics Welcomes C Lowry Barnes, M.D. to Leadership Team as Medical Director
MicroPort Orthopedics, a global leader in orthopedic devices and technologies, today announces that C. Lowry Barnes, MD, Chair of Orthopaedics at the University of Arkansas for Medical Sciences Health, has officially joined the company’s leadership team as Medical Director. Dr. Barnes is a board-certified, fellowship-trained total joint surgeon with a special interest in hip and knee ...
-
OrthoGrid Systems, Inc. Announces Launch of New OrthoGrid Hip Preservation Software Application for Peri Acetabular Osteotomy and Femoroplasty
OrthoGrid® Systems, Inc, a global medtech leader on a mission to digitally transform intraoperative musculoskeletal surgery, announces the launch of ts new OrthoGrid Hip Preservation Application after receiving FDA clearance on February 18, 2021. The OrthoGrid Hip Preservation App is the latest version of OrthoGrid’s patented, distortion correcting, intraoperative-alignment technology ...
-
First Primary Total Knee Arthroplasty with the PEEK-OPTIMA Femoral Component
Maxx Orthopedics, in Partnership with Invibio Biomaterial Solutions, Announces First Primary Total Knee Arthroplasty with the PEEK-OPTIMA™ Femoral Component. Norristown, PA (USA) July 12, 2021: Maxx Orthopedics, Inc., and Invibio Biomaterial Solutions together announced the successful study initiation and first patients to be implanted with the new, all polymer, PEEK-OPTIMA™ femoral ...
Need help finding the right suppliers? Try XPRT Sourcing. Let the XPRTs do the work for you